Abstract
Lithium (Li) continues to be a standard small compound used for the treatment of neurological disorders. Besides neuronal cells, Li is also known to affect immune cell function. In spite of its clinical use, potential mechanisms by which Li modulates immune cells, especially macrophages and its clinical relevance in bipolar patients are not well understood. Here, we provide an overview of the literature with regard to Li’s effects on monocytes and macrophages. We have also included some of our results showing that Li differentially modulates chemokine gene expression in the absence and presence of Toll-like receptor-4 stimulation in a human macrophage model. Given that Li has a wide range of intracellular targets both in macrophages as well as in other cell types, more studies are needed to further understand the mechanistic basis of Li’s effect in neurological and other inflammatory diseases. These studies could undoubtedly identify new therapeutic targets for treating such diseases.
Similar content being viewed by others
References
Anur P, Yates J, Garbati MR, Vanderwerf S, Keeble W, Rathbun K, Hays LE, Tyner JW, Svahn J, Cappelli E, Dufour C, Bagby GC (2012) p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes. Blood 119:1992–2002
Arena A, Capozza AB, Orlando ME, Curro F, Losi E, Chillemi S, Mesiti M, Merendino RA (1997) In vitro effects of lithium chloride on TNF alpha and IL-6 production by monocytes from breast cancer patients. J Chemother (Florence, Italy) 9:219–226
Balon R, Berchou R (1986) Hematologic side effects of psychotropic drugs. Psychosomatics 27:119–120,125–117
Beurel E, Jope RS (2008) Differential regulation of STAT family members by glycogen synthase kinase-3. J Biol Chem 283:21934–21944
Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W (1991) Lithium chloride potentiates tumor necrosis factor-induced and interleukin 1-induced cytokine and cytokine receptor expression. Cytokine 3:284–291
Beyaert R, Schulze-Osthoff K, Van Roy F, Fiers W (1992) Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 22:2181–2184
Chen K, Wu Y, Zhu M, Deng Q, Nie X, Li M, Wu M, Huang X (2013) Lithium chloride promotes host resistance against Pseudomonas aeruginosa keratitis. Mol Vision 19:1502–1514
Chiu CT, Chuang DM (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128:281–304
Choi SE, Jang HJ, Kang Y, Jung JG, Han SJ, Kim HJ, Kim DJ, Lee KW (2010) Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice. Vasc Pharmacol 53:264–272
Conductier G, Blondeau N, Guyon A, Nahon JL, Rovere C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224(1–2):93–100
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56
De Meyer I, Martinet W, Van Hove CE, Schrijvers DM, Hoymans VY, Van Vaeck L, Fransen P, Bult H, De Meyer GR (2011) Inhibition of inositol monophosphatase by lithium chloride induces selective macrophage apoptosis in atherosclerotic plaques. Br J Pharmacol 162:1410–1423
De Sarno P, Axtell RC, Raman C, Roth KA, Alessi DR, Jope RS (2008) Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 181:338–345
Gualtieri RJ, Berne RM, McGrath HE, Huster WJ, Quesenberry PJ (1986) Effect of adenine nucleotides on granulopoiesis and lithium-induced granulocytosis in long-term bone marrow cultures. Exp Hematol 14:689–695
Hart DA, Done SJ, Benediktsson H, Lenz SP (1994) Partial characterization of the enhanced survival of female NZB/W mice treated with lithium chloride. Int J Immunopharmacol 16:825–833
Hui W, Litherland GJ, Jefferson M, Barter MJ, Elias MS, Cawston TE, Rowan AD, Young DA (2010) Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway. Rheumatology 49:2043–2053
Hull M, Lee E, Lee T, Anand N, Lalone V, Parameswaran N (2013) Lithium chloride induces TNFalpha in mouse macrophages via MEK-ERK-dependent pathway. J Cell Biochem 115(1):71–80
Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR (2013) Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis 19:1586–1597
Kleinerman ES, Knowles RD, Blick MB, Zwelling LA (1989) Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin. J Leukoc Biol 46:484–492
Knijff EM, Breunis MN, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, Nolen WA, Drexhage HA (2007) An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord 9:743–753
Kucharz EJ, Sierakowski SJ, Goodwin JS (1993) Lithium in vitro enhances interleukin-2 production by T cells from patients with systemic lupus erythematosus. Immunopharmacol Immunotoxicol 15:515–523
Lee T, Lee E, Irwin R, Lucas PC, McCabe LR, Parameswaran N (2013) beta-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol 182:1114–1123
Leemasawatdigul K, Gappa-Fahlenkamp H (2011) Effect of storage conditions on the stability of recombinant human MCP-1/CCL2. Biol J Int Assoc Biol Stand 39:29–32
Lehto SM, Niskanen L, Herzig KH, Tolmunen T, Huotari A, Viinamaki H, Koivumaa-Honkanen H, Honkalampi K, Ruotsalainen H, Hintikka J (2010) Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 35:226–232
Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32:1749–1756
Liu KJ, Lee YL, Yang YY, Shih NY, Ho CC, Wu YC, Huang TS, Huang MC, Liu HC, Shen WW, Leu SJ (2011) Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. J Cell Physiol 226:424–433
Maes M, Song C, Lin AH, Pioli R, Kenis G, Kubera M, Bosmans E (1999) In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology 143:401–407
Merendino RA, Arena A, Gangemi S, Ruello A, Losi E, Bene A, D’Ambrosio FP (2000a) In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients. Tumori 86:149–152
Merendino RA, Arena A, Gangemi S, Ruello A, Losi E, Bene A, Valenti A, D’Ambrosio FP (2000b) In vitro effect of lithium chloride on interleukin-15 production by monocytes from IL-breast cancer patients. J Chemother (Florence, Italy) 12:252–257
Moresco EM, LaVine D, Beutler B (2011) Toll-like receptors. Curr Biol CB 21:R488–R493
Murphy DL, Goodwin FK, Bunney WE Jr (1971) Leukocytosis during lithium treatment. Am J Psychiatry 127:1559–1561
Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737
Nahman S, Belmaker RH, Azab AN (2012) Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells. Innate Immun 18:447–458
Packiriswamy N, Lee T, Raghavendra PB, Durairaj H, Wang H, Parameswaran N (2013) G-protein-coupled receptor kinase-5 mediates inflammation but does not regulate cellular infiltration or bacterial load in a polymicrobial sepsis model in mice. J Innate Immun 5:401–413
Patial S, Shahi S, Saini Y, Lee T, Packiriswamy N, Appledorn DM, Lapres JJ, Amalfitano A, Parameswaran N (2011a) G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFkappaB activation in primary macrophages and modulates inflammation in vivo in mice. J Cell Physiol 226:1323–1333
Patial S, Saini Y, Parvataneni S, Appledorn DM, Dorn GW 2nd, Lapres JJ, Amalfitano A, Senagore P, Parameswaran N (2011b) Myeloid-specific GPCR kinase-2 negatively regulates NF-kappaB1p105-ERK pathway and limits endotoxemic shock in mice. J Cell Physiol 226:627–637
Roskoski R Jr (2012) ERK1/2 MAP kinases: structure, function, and regulation. Pharm Res Off J Italian Pharmacol Soc 66:105–143
Savarin-Vuaillat C, Ransohoff RM (2007) Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurother J Am Soc Exp NeuroTher 4:590–601
Sharma D, Malik A, Lee E, Britton RA, Parameswaran N (2013) Gene dosage-dependent negative regulatory role of beta-arrestin-2 in polymicrobial infection-induced inflammation. Infect Immun 81:3035–3044
Shenkman L, Borkowsky W, Shopsin B (1980) Lithium as an immunologic adjuvant. Med Hypotheses 6:1–6
Shenkman L, Borkowsky W, Holzman RS, Shopsin B (1978) Enhancement of lymphocyte and macrophage function in vitro by lithium chloride. Clin Immunol Immunopathol 10:187–192
Shopsin B, Friedmann R, Gershon S (1971) Lithium and leukocytosis. Clin Pharmacol Ther 12:923–928
Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Investig 122:787–795
Tang A, Sharma A, Jen R, Hirschfeld AF, Chilvers MA, Lavoie PM, Turvey SE (2012) Inflammasome-mediated IL-1beta production in humans with cystic fibrosis. PloS One 7:e37689
Tisman G, Herbert V, Rosenblatt S (1973) Evidence that lithium induces human granulocyte proliferation: elevated serum vitamin B 12 binding capacity in vivo and granulocyte colony proliferation in vitro. Br J Haematol 24:767–771
Tsuji S, Morinobu S, Tanaka K, Kawano K, Yamawaki S (2003) Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression. J Neural Transm 110:413–425
Vuletic S, Dong W, Wolfbauer G, Tang C, Albers JJ (2011) PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages. Biochim Biophys Acta 1813:1917–1924
Waisberg M, Cerqueira GC, Yager SB, Francischetti IM, Lu J, Gera N, Srinivasan P, Miura K, Rada B, Lukszo J, Barbian KD, Leto TL, Porcella SF, Narum DL, El-Sayed N, Miller LH, Pierce SK (2012) Plasmodium falciparum merozoite surface protein 1 blocks the proinflammatory protein S100P. Proc Natl Acad Sci U S A 109:5429–5434
Wang L, Zhang L, Zhao X, Zhang M, Zhao W, Gao C (2013) Lithium Attenuates IFN-beta Production and Antiviral Response via Inhibition of TANK-Binding Kinase 1 Kinase Activity. J Immunol. 191(8):4392–4398
Wang Y, Huang WC, Wang CY, Tsai CC, Chen CL, Chang YT, Kai JI, Lin CF (2009) Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis. Br J Pharmacol 157:1004–1013
Watanabe S, Taguchi K, Nakashima Y, Ebara T, Iguchi K (1974) Leukocytosis during lithium treatment and its correlation to serum lithium level. Folia Psychiatr Neurol Jpn 28:161–165
Zhang M, Jin W, Zhou X, Yu J, Lee AJ, Sun SC (2009) Deregulation of Tpl2 and NF-kappaB signaling and induction of macrophage apoptosis by the anti-depressant drug lithium. Cell Signal 21:559–566
Zhen X, Torres C, Friedman E (2002) Lithium regulates protein tyrosine phosphatase activity in vitro and in vivo. Psychopharmacology 162:379–384
Acknowledgments
We gratefully acknowledge the support from NIH (grants HL095637, AR055726 and AR056680 to N.P.).
Conflict of Interest
Authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raghavendra, P.B., Lee, E. & Parameswaran, N. Regulation of Macrophage Biology by Lithium: A New Look at an Old Drug. J Neuroimmune Pharmacol 9, 277–284 (2014). https://doi.org/10.1007/s11481-013-9516-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-013-9516-y